Pfizer Beats Estimates for the First Quarter
Motley Fool
The pharma giant's earnings surpassed Wall Street's expectations despite revenue declines from its COVID-19 products.
The pharma giant's earnings surpassed Wall Street's expectations despite revenue declines from its COVID-19 products.
Company on track to commence Phase 1 human clinical study of PALI-2108 for the treatment of Ulcerative Colitis (UC) before year..
Dublin, May 01, 2024 (GLOBE NEWSWIRE) -- The "Global Fill Finish Manufacturing Market by Product (Consumables (Pre-fillable..